BiPAP辅助治疗肺心病顽固性心力衰竭60例疗效观察

Observation on the effect of BiPAP adjuvant therapy in the treatment of 60 patients with intractable heart failure due to pulmonary heart disease

目的:探讨双水平气道正压通气(BiPAP)辅助治疗肺心病顽固性心力衰竭患者的临床疗效。方法:将120例肺心病顽固性心力衰竭患者根据入院顺序分为观察组与对照组各60例。对照组给予常规治疗及氨溴索、酚妥拉明、多巴酚丁胺等药物治疗,观察组在对照组治疗基础上给予BiPAP辅助治疗。比较两组临床疗效及观察组BiPAP治疗前后血气分析及心率、呼吸情况。结果:观察组临床疗效优于对照组(P<0.05),观察组BiPAP治疗前后血气分析及心率、呼吸情况比较差异有统计学意义(P<0.05)。结论:BiPAP辅助治疗能够改善肺心病顽固性心力衰竭患者的通气功能,提高疗效,值得临床推广应用。

Objective：To investigate the clinical curative effect in the treatment of intractable heart failure due to pulmonary heart disease with bi-level positive airway pressure ventilation（BiPAP） adjuvant therapy.Methods：120 patients with intractable heart failure were divided into an observation group and a control group（60 cases in each group） according to the sequence of admission.The conventional treatment combined with drug therapy with ambroxol,phentolamine and dobutamine were taken in the control group and extra BiPAP adjuvant therapy was given to the patients in the observation group based on the treatment mentioned in the control group.The clinical curative effect was compared between the two groups and the blood gas analysis,heart rate and breathing were compared before and after BiPAP adjuvant therapy in the observation group.Results：The clinical curative effect was better in the observation group than the control group（P0.05）;the differences in the comparison of blood gas analysis,heart rate and breathing were statistically significant before and after BiPAP adjuvant therapy in the observation group（P0.05）.Conclusion：BiPAP adjuvant therapy can improve ventilatory function and the curative effect in the treatment of intractable heart failure due to pulmonary heart disease.